Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry.
暂无分享,去创建一个
Loïc Dayon | Martin Kussmann | Arne Astrup | Irina Irincheeva | Ornella Cominetti | Antonio Núñez Galindo | John Corthésy | Sergio Oller Moreno | Armand Valsesia | Wim H M Saris | Jörg Hager | A. Valsesia | A. Astrup | W. Saris | M. Kussmann | L. Dayon | J. Hager | I. Irincheeva | A. Núñez Galindo | O. Cominetti | Sergio Oller Moreno | J. Corthésy
[1] Gil Alterovitz,et al. Automation, parallelism, and robotics for proteomics , 2006, Proteomics.
[2] Takuji Nishimura,et al. Mersenne twister: a 623-dimensionally equidistributed uniform pseudo-random number generator , 1998, TOMC.
[3] M. Visser,et al. Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.
[4] L. Sottrup-jensen,et al. Characterization of human pregnancy zone protein. Comparison with human alpha 2-macroglobulin. , 1985, The Journal of biological chemistry.
[5] R. Cole,et al. The Plasma Proteome Identifies Expected and Novel Proteins Correlated with Micronutrient Status in Undernourished Nepalese Children 1 – 3 , 2013 .
[6] Alan A. Doucette,et al. Proteomic Workflows for Biomarker Identification Using Mass Spectrometry — Technical and Statistical Considerations during Initial Discovery , 2013, Proteomes.
[7] Ludovic C. Gillet,et al. Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.
[8] T. Larsen,et al. The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries – a comprehensive design for long‐term intervention , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[9] A. Astrup,et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. , 2010, The New England journal of medicine.
[10] M. Kussmann,et al. Proteomics of human plasma: A critical comparison of analytical workflows in terms of effort, throughput and outcome , 2013 .
[11] N. Anderson,et al. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. , 2010, Clinical chemistry.
[12] D. Figeys,et al. Multiplexed proteomic reactor for the processing of proteomic samples. , 2007, Analytical chemistry.
[13] Joshua LaBaer,et al. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. , 2013, Journal of proteome research.
[14] Amanda G. Paulovich,et al. An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers* , 2009, Molecular & Cellular Proteomics.
[15] D. N. Perkins,et al. Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.
[16] David M. Simcha,et al. Tackling the widespread and critical impact of batch effects in high-throughput data , 2010, Nature Reviews Genetics.
[17] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[18] Stefan Enroth,et al. Identification of genetic variants influencing the human plasma proteome , 2013, Proceedings of the National Academy of Sciences.
[19] F. Regnier,et al. A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples , 2011, Journal of Translational Medicine.
[20] Ruedi Aebersold,et al. Targeted proteomic strategy for clinical biomarker discovery , 2009, Molecular oncology.
[21] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[23] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.
[24] C. Silliman,et al. Proteomic analyses of human plasma: Venus versus Mars , 2012, Transfusion.
[25] Ruedi Aebersold,et al. Quantitative variability of 342 plasma proteins in a human twin population , 2015 .
[26] A. Astrup,et al. Mechanisms of weight maintenance under high- and low-protein, low-glycaemic index diets. , 2011, Molecular nutrition & food research.
[27] M. Kussmann,et al. Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. , 2014, Journal of proteome research.
[28] C. Longcope,et al. Sex hormone-binding globulin concentration: differences among commercially available methods. , 2000, Clinical chemistry.
[29] Bernhard Kuster,et al. Robust and Sensitive iTRAQ Quantification on an LTQ Orbitrap Mass Spectrometer*S , 2008, Molecular & Cellular Proteomics.
[30] K. Nelson,et al. Urine Sample Preparation in 96-Well Filter Plates for Quantitative Clinical Proteomics , 2014, Analytical chemistry.
[31] J. Grudzinskas,et al. Circulating levels of pregnancy zone protein: normal range and the influence of age and gender. , 1981, Clinica chimica acta; international journal of clinical chemistry.
[32] A. Tchernof,et al. Sex Steroid Hormones, Sex Hormone-Binding Globulin, and Obesity in Men and Women , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[33] S. Pennington,et al. Why have so few proteomic biomarkers “survived” validation? (Sample size and independent validation considerations) , 2014, Proteomics.
[34] Martijn Pinkse,et al. A high‐throughput sample preparation method for cellular proteomics using 96‐well filter plates , 2013, Proteomics.
[35] D. Hochstrasser,et al. Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. , 2008, Analytical chemistry.
[36] Larry Gold,et al. Beyond antibodies: New affinity reagents to unlock the proteome , 2014, Proteomics.
[37] H. Langen,et al. Antibody‐based proteomics and biomarker research—Current status and limitations , 2014, Proteomics.
[38] B. Pedersen,et al. Calprotectin — A Novel Marker of Obesity , 2009, PloS one.
[39] David J Hunter,et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. , 2009, The New England journal of medicine.
[40] Hasmik Keshishian,et al. Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury* , 2015, Molecular & Cellular Proteomics.